Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas
Open Access
- 1 June 2020
- Vol. 9 (6), 1538
- https://doi.org/10.3390/cells9061538
Abstract
Background: Neuron glial antigen 2 or chondroitin sulphate proteoglycan 4 (NG2/CSPG4) is expressed by immature precursors/progenitor cells and is possibly involved in malignant cell transformation. The aim of this study was to investigate its role on the progression and survival of sixty-one adult gliomas and nine glioblastoma (GB)-derived cell lines. Methods: NG2/CSPG4 protein expression was assessed by immunohistochemistry and immunofluorescence. Genetic and epigenetic alterations were detected by molecular genetic techniques. Results: NG2/CSPG4 was frequently expressed in IDH-mutant/1p19q-codel oligodendrogliomas (59.1%) and IDH-wild type GBs (40%) and rarely expressed in IDH-mutant or IDH-wild type astrocytomas (14.3%). Besides tumor cells, NG2/CSPG4 immunoreactivity was found in the cytoplasm and/or cell membranes of reactive astrocytes and vascular pericytes/endothelial cells. In GB-derived neurospheres, it was variably detected according to the number of passages of the in vitro culture. In GB-derived adherent cells, a diffuse positivity was found in most cells. NG2/CSPG4 expression was significantly associated withEGFRgene amplification (p= 0.0005) and poor prognosis (p= 0.016) in astrocytic tumors. Conclusion: The immunoreactivity of NG2/CSPG4 provides information on the timing of the neoplastic transformation and could have prognostic and therapeutic relevance as a promising tumor-associated antigen for antibody-based immunotherapy in patients with malignant gliomas.Funding Information
- Compagnia di San Paolo (2016.AAI2705.U3302)
- Fondazione Cassa di Risparmio di Vercelli (Not assigned)
This publication has 95 references indexed in Scilit:
- Asymmetry-Defective Oligodendrocyte Progenitors Are Glioma PrecursorsCancer Cell, 2011
- Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastomaActa Neuropathologica, 2011
- Mosaic Analysis with Double Markers Reveals Tumor Cell of Origin in GliomaCell, 2011
- NG2 cells are not a major source of reactive astrocytes after neocortical stab wound injuryGlia, 2011
- Non-Stem Cell Origin for OligodendrogliomaCancer Cell, 2010
- Neuron-glia synapses in the brainBrain Research Reviews, 2010
- The NG2 proteoglycan promotes oligodendrocyte progenitor proliferation and developmental myelinationNeuroscience, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signalingOncogene, 2008
- Differential phosphorylation of NG2 proteoglycan by ERK and PKCα helps balance cell proliferation and migrationThe Journal of cell biology, 2007